Monitoring and maintaining a higher tacrolimus trough level in the first month after transplantation is essential to avoid acute rejection, according to investigators. Maintaining a tacrolimus trough ...

Kidney transplant recipients typically take the immunosuppressant drug tacrolimus to prevent rejection, and some patients experience large fluctuations in blood levels of tacrolimus even when the dose ...

Please provide your email address to receive an email when new articles are posted on . In a retrospective pediatric cohort study, researchers observed 426 patients who underwent kidney-only ...

Tacrolimus is a mainstay immunosuppressant used to prevent rejection in kidney transplant recipients. However, its narrow therapeutic index necessitates routine monitoring, as intrapatient variability ...

More patients with atopic dermatitis achieved mild disease severity by 1 month of treatment with adjuvant dupilumab and tacrolimus vs dupilumab alone. A greater proportion of patients with atopic ...

In paediatric kidney transplant recipients, high variability in tacrolimus trough blood levels was significantly associated with allograft rejection occurring beyond 12 months post-transplant; however ...

Please provide your email address to receive an email when new articles are posted on . Tacrolimus alone had a dose-response relationship with achieving complete renal response in SLE. Combination ...

CINCINNATI—Transplant researchers at the University of Cincinnati (UC) have received a grant from the U.S. Food and Drug Administration to study the safety and efficacy of a generic immunosuppressive ...